Anton, Onto cgp. I think the bio run and the realignment of cgp management are critical here. I don't think 20c is out of the question here. Am I a nutter ?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025